Telemarketing-driven healthcare fraud schemes generate patient leads through call centers, then route those leads to a physician willing to sign an order without an adequate patient evaluation. The Department of Justice and HHS Office of Inspector General have made these schemes a recurring feature of the annual National Health Care Fraud Enforcement Action, charging telemarketing and telemedicine executives alongside the physicians who sign the resulting orders. A physician who signs such orders, even without direct knowledge of the kickback arrangement, can face exposure under the Anti-Kickback Statute and the federal health care fraud statute. The stakes include indictment, loss of a medical license, and personal liability that outlasts the telemarketing company itself.
How Telemarketing-Driven Fraud Schemes Operate
The mechanics repeat across cases. A marketing company builds lists of Medicare beneficiaries, then cold-calls them offering a brace, a genetic test, or a topical cream at no cost. Once a beneficiary agrees, the marketer routes the lead to a telehealth platform, where a physician who has never treated the patient signs an order or prescription after a call lasting only a few minutes. The Department of Justice's Criminal Division has described physicians in these schemes as ones who "had no relationship with the patients, rarely spoke to them, and made no determination of medical necessity". The order becomes the basis for a claim submitted to Medicare by a durable medical equipment supplier, a genetic testing laboratory, or a pharmacy, and a share of the reimbursement flows back to the marketer and the physician as a kickback, often structured as a per-order fee.
The DOJ Enforcement Pattern
Telemarketing-driven schemes have anchored the Department of Justice's National Health Care Fraud Enforcement Action for several years running. In June 2025, the department announced charges against 324 defendants, including 96 licensed medical professionals, in connection with over $14.6 billion in alleged fraud, the largest such action to date. Within it, 49 defendants faced charges tied to telemedicine and genetic testing schemes generating more than $1.17 billion in fraudulent Medicare claims, including a South Florida case built on beneficiaries recruited through deceptive telemarketing for durable medical equipment and genetic testing. Smaller prosecutions follow the same pattern: in November 2025, two operators of a telemarketing company were sentenced to federal prison for recruiting beneficiaries for unnecessary cancer genetic testing and soliciting kickbacks on those referrals. Cases built on this model often proceed on parallel civil and criminal tracks at once, since the referral pattern behind a kickback charge can also support a civil False Claims Act suit.
Where Legitimate Physicians Get Swept In
A physician does not need to have organized a scheme to end up charged in it. Investigators typically build these cases from the claims data outward, starting with a telemarketing vendor and following the money to every physician whose national provider identifier appears on the resulting orders. A physician who accepted a per-order payment, without asking how the platform generated its patients, can be named in the same indictment as the marketers, even without ever speaking to Medicare directly. Volume is often the first flag: a prescriber whose orders originate almost entirely from one vendor, with little independent patient contact, fits a pattern investigators are trained to isolate. For many physicians, a grand jury subpoena or a target letter is the first sign that a vendor they worked with has already become the subject of a federal investigation.
Signing an order generated by a telemarketing lead, without independently examining the patient, can expose the signing physician to the same Anti-Kickback Statute and health care fraud liability as the marketers who built the scheme.
Reducing Exposure to Telemarketing-Generated Referrals
Physicians who work with telehealth platforms can reduce exposure in concrete ways. Document an independent medical necessity determination for every order, rather than relying on a platform's intake questionnaire alone. Decline compensation tied to order volume, since a per-order fee is the feature investigators look for first. Ask a vendor how it generated the patient list before signing anything it provides, and review any platform agreement against the Anti-Kickback Statute's safe harbors before signing, not after a civil investigative demand arrives.
Why Early Legal Counsel Is Critical
It is critical that physicians promptly retain experienced healthcare defense counsel upon receiving a subpoena, audit notice, or other government inquiry tied to a telemarketing-driven referral arrangement. Early legal intervention can protect the physician's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the physician's behalf. Delaying legal representation can significantly affect the outcome of a matter.
How Health Law Alliance Can Help
Health Law Alliance has handled 5,000+ matters across healthcare regulatory and criminal defense over 25+ years, including telemarketing-driven referral investigations and the grand jury subpoenas that follow a marketing vendor's indictment. If you signed orders generated by a telehealth platform and are now facing a government inquiry, contact Health Law Alliance's healthcare fraud defense attorneys for a free, confidential consultation.
